Inclusion Criteria

You may be eligible for this study if you:

• Are HIV-positive.
• Have a CD4 count greater than 100 cells/mm3.
• Have healed CMV retinitis after receiving anti-CMV therapy for at least 8 weeks within 3 months prior to study entry.
• Have taken antiretroviral therapy for at least 8 weeks prior to study entry; combination therapy must include at least 2 of the following: protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs), or non-nucleoside reverse transcriptase inhibitors (NNRTIs).
• Have a life expectancy of at least 6 months.
• Are at least 13 years old (need consent if under 18).

Exclusion Criteria

You will not be eligible for this study if you:

• Have any unstable or severe medical conditions that would keep you from completing the study.
• Require chemotherapy or radiation therapy.
• Have a history of certain eye disorders.